Related Experiment Video
Updated: Jan 22, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
VPS35 regulates tau phosphorylation and neuropathology in tauopathy
Alana N Vagnozzi1, Jian-Guo Li1, Jin Chiu1
1Alzheimer's Center at Temple, Department of Pharmacology, Philadelphia, PA, 19140, USA.
Abstract:
The vacuolar protein sorting 35 (VPS35) is a major component of the retromer recognition core complex which regulates intracellular protein sorting and trafficking. Deficiency in VPS35 by altering APP/Aβ metabolism has been linked to late-onset Alzheimer's disease. Here we report that VPS35 is significantly reduced in Progressive Supra-nuclear Palsy and Picks' disease, two distinct primary tauopathies. In vitro studies show that overexpression of VPS35 leads to a reduction of pathological tau in neuronal cells, whereas genetic silencing of VPS35 results in its accumulation. Mechanistically the availability of active cathepsin D mediates the effect of VPS35 on pathological tau accumulation. Moreover, in a relevant transgenic mouse model of tauopathy, down-regulation of VPS35 results in an exacerbation of motor and learning impairments as well as accumulation of pathological tau and loss of synaptic integrity. Taken together, our data identify VPS35 as a novel critical player in tau metabolism and neuropathology, and a new therapeutic target for human tauopathies.
Insights
Vacuolar protein sorting 35 (VPS35) deficiency is linked to tauopathies. Reduced VPS35 exacerbates tau pathology and cognitive deficits, identifying VPS35 as a therapeutic target for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Vacuolar protein sorting 35 (VPS35) is crucial for intracellular trafficking and linked to Alzheimer's disease via APP/Aβ metabolism.
- VPS35 levels are notably decreased in tauopathies like Progressive Supranuclear Palsy and Pick's disease.
Purpose of the Study:
- To investigate the role of VPS35 in tau metabolism and neuropathology.
- To explore VPS35 as a potential therapeutic target for tauopathies.
Main Methods:
- In vitro studies involving overexpression and genetic silencing of VPS35 in neuronal cells.
- Analysis of VPS35 levels in human tauopathy tissues.
- Assessment of motor and learning functions, tau pathology, and synaptic integrity in a transgenic mouse model of tauopathy.
Main Results:
- VPS35 overexpression reduced pathological tau, while VPS35 silencing increased tau accumulation, mediated by cathepsin D.
- VPS35 down-regulation in a mouse model worsened motor and learning impairments, elevated pathological tau, and caused synaptic damage.
Conclusions:
- VPS35 plays a critical role in regulating tau metabolism and neuropathology.
- VPS35 represents a novel therapeutic target for human tauopathies.
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Kendall's Tau Test
A τ value of +1 indicates...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Negative Regulator Molecules
Positive Regulator Molecules

